Structural biology and artificial intelligence team up to create the first universal vaccine against alphaviruses.
A research team at the University of Texas Medical Branch (UTMB) has achieved a milestone in modern vaccinology by creating a pioneering computational system that accelerates the response to emerging pathogens. Under the leadership of Dr Nikos Vasilakis, professor and deputy director of research, and Dr Peter McCaffrey, director of UTMB's AI centre, the study has been published in the prestigious journal Science Advances.
The threat of alphaviruses and the need for a global solution
Alphaviruses are mosquito-borne viruses that cause diseases such as chikungunya and equine encephalitis, posing a serious threat to public health. With the constant emergence and re-emergence of these viruses around the world, faster vaccine development methods than traditional processes are required.
To address this challenge, researchers have created an iterative design system that combines machine learning with structural biology. This platform analyses viral proteins for key epitopes, essential fragments capable of triggering an effective immune response.
The pan-alphavirus vaccine revolution
The innovative approach of this study has identified epitopes with high immunogenicity, stability and genetic coverage, essential for effective protection against a wide range of alphaviruses. Rather than developing virus-specific vaccines, a universal vaccine capable of providing broad and proactive protection against the entire viral family is being sought.
This breakthrough represents the first time artificial intelligence has been used and experimentally validated in the creation of a pan-gene vaccine candidate. Beyond alphaviruses, this process lays the groundwork for future efforts against other pathogens, setting a precedent in modern vaccinology.
Implications and future of research
In laboratory testing, the selected epitopes were shown to effectively activate T cells in animal and human models. This activation triggered the release of key immune molecules, paving the way for a new generation of global vaccines that promise more effective and broader protection.
In short, the combination of structural biology and artificial intelligence has marked a turning point in the search for universal vaccines. This pioneering study not only offers a solution to the threat of alphaviruses, but also sets a new paradigm in the fight against emerging infectious diseases.
Source: www.consalud.es
Español 
English (UK) 
